Wave Life Sciences WVE SG — Deferred Tax Assets Operating Loss Carryforwards

Similar metrics at other companies

LACCA — Deferred Tax Assets Operating Loss Carryforwards

$16.2M+1.9%

LACUS — Deferred Tax Assets Operating Loss Carryforwards

$288.5M+12.0%

LSAKUS — Deferred Tax Assets Operating Loss Carryforwards

$30.8M—

LSAKZA — Deferred Tax Assets Operating Loss Carryforwards

$212.1M—

VSATGB — Deferred Tax Assets Operating Loss Carryforwards

$64.2M—

VHI

VHIUS — Deferred Tax Assets Operating Loss Carryforwards

$12.2M—

FAQ

What is Wave Life Sciences's SG — deferred tax assets operating loss carryforwards?

Wave Life Sciences (WVE) reported SG — deferred tax assets operating loss carryforwards of $144.8M in Q4 2025.

How has Wave Life Sciences's SG — deferred tax assets operating loss carryforwards changed year-over-year?

Wave Life Sciences's SG — deferred tax assets operating loss carryforwards increased by 9.1% year-over-year, from $132.7M to $144.8M.

What does SG — deferred tax assets operating loss carryforwards mean?

This metric quantifies the value of tax losses that can be carried forward to offset future taxable income within the segment. It represents a potential future tax benefit that is contingent upon the segment achieving future profitability.